GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (CHIX:GALDz) » Definitions » EV-to-Revenue

Galderma Group AG (CHIX:GALDZ) EV-to-Revenue : 7.11 (As of Jun. 03, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Galderma Group AG EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Galderma Group AG's enterprise value is CHF28,175 Mil. Galderma Group AG's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was CHF3,964 Mil. Therefore, Galderma Group AG's EV-to-Revenue for today is 7.11.

The historical rank and industry rank for Galderma Group AG's EV-to-Revenue or its related term are showing as below:

CHIX:GALDz' s EV-to-Revenue Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: 7.11

CHIX:GALDz's EV-to-Revenue is ranked worse than
81.29% of 973 companies
in the Drug Manufacturers industry
Industry Median: 2.43 vs CHIX:GALDz: 7.11

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-06-03), Galderma Group AG's stock price is CHF110.70. Galderma Group AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was CHF16.67. Therefore, Galderma Group AG's PS Ratio for today is 6.64.


Galderma Group AG EV-to-Revenue Historical Data

The historical data trend for Galderma Group AG's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galderma Group AG EV-to-Revenue Chart

Galderma Group AG Annual Data
Trend Dec23 Dec24
EV-to-Revenue
- 6.55

Galderma Group AG Semi-Annual Data
Jun23 Dec23 Jun24 Dec24
EV-to-Revenue - - - -

Competitive Comparison of Galderma Group AG's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Galderma Group AG's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Galderma Group AG's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Galderma Group AG's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Galderma Group AG's EV-to-Revenue falls into.


;
;

Galderma Group AG EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Galderma Group AG's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=28175.004/3963.579
=7.11

Galderma Group AG's current Enterprise Value is CHF28,175 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Galderma Group AG's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was CHF3,964 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Galderma Group AG  (CHIX:GALDz) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Galderma Group AG's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=110.70/16.669
=6.64

Galderma Group AG's share price for today is CHF110.70.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2024 was CHF16.67.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Galderma Group AG EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Galderma Group AG's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Galderma Group AG Business Description

Traded in Other Exchanges
Address
Zahlerweg 10, Zug, CHE, 6300
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.

Galderma Group AG Headlines

No Headlines